Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia.Circ Res. 2021; 128: 1747-1765
- Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.Eur J Prev Cardiol. 2022; 29: 938-946
- Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study.J Hepatol. 2022; 77: 931-938
- Mendelian randomization.Jama. 2017; 318: 1925-1926
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(☆).J Hepatol. 2020; 73: 505-515
- A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.Nat Genet. 2022; 54: 761-771
- Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.Nat Genet. 2018; 50: 1234-1239
Author names in bold designate shared co-first authorship.